Angiogenic switch occurs late in squamous cell carcinomas of human skin by Strieth, S et al.
It is now well established that malignant tumours critically depend
on neovascularization for continued growth, invasion and forma-
tion of metastases (Folkman, 1995). Obviously, new vasculariza-
tion promotes tumour growth by improving the exchange of
nutrients, oxygen and waste products. There is increasing evidence
that, in addition to this perfusion effect, endothelial cells release
important paracrine growth factors for tumour cells (Hamada et al,
1992; Weidner, 1995; Rak et al, 1996). Also, the invasive behav-
iour of endothelial cells at the tips of growing capillaries is facili-
tated by their secretion of matrix-degrading enzymes, which are
likely to facilitate spreading of tumour cells into the connective
tissue (Pyke et al, 1991). Thus, by the additive impact of the perfu-
sion and paracrine growth effects with the production of proteases,
activated endothelia may significantly contribute to tumour
growth, invasion and metastasis.
Within the last decade a number of studies on tumours of the
breast, cervix, prostate and of malignant melanoma (reviewed in
Weidner, 1995) have revealed a correlation of increased intra-
tumour microvessel density with different parameters of tumour
aggressiveness such as relapses, formation of metastases, or
decreased patient survival. However, there have also been contra-
dictory results showing no such correlations (Carrau et al, 1995;
Tahan and Stein, 1995) and it is not clear whether this discrepancy
is due to intratumoural heterogeneity, tumour type and localization
or differences in analytical methods. Notably, many of these
studies which did not demonstrate a correlation between tumour
vessel density and progression had analysed squamous cell carci-
nomas (SCCs) of the head and neck (Carrau et al, 1995; Tahan and
Stein, 1995).
In skin, the prognostic significance of tumour vascularity for a
higher probability to progress to more advanced tumour stages has
been documented for melanomas, in particular for those exhibiting
intermediate thickness and being classified as ‘low risk tumours’
(Srivastava et al, 1988; Marcoval et al, 1997). As far as SCCs are
concerned, there are small amounts of data available of tumours of
the skin (Urbach and Graham, 1962; Tahan and Stein, 1995;
Weninger et al, 1996, 1997) which do not show a strong correla-
tion of angiogenesis with tumour progression except for basal cell
carcinomas (Staibano et al, 1996).
Although it is common finding that malignant tumours have
increased vascularization, less is known about the regulation of the
‘switch to the angiogenic phenotype’ (Hanahan and Folkman,
1996). In particular, it is not clear whether this crucial step in
tumour development generally precedes the conversion of pre-
malignant to malignant neoplasms, as data from transgenic mouse
models have shown (Coussens et al, 1996; Smith-McCune et al,
1997). Patient data from mammary gland, uterine cervix and
prostate have confirmed these experimental data, demonstrating
the onset of increased vascularization in premalignant stages,
mostly in intraepithelial neoplasia (Brawer et al, 1994; Guidi et al,
1994; Smith-McCune and Weidner, 1994).
In skin, as in other organs, epithelial neoplasia develops through
preneoplastic stages, but little is known about the association of
angiogenesis with these different stages of epithelial carcino-
genesis. In humans, 60% of SCCs of the skin develop through
defined stages called actinic or solar keratosis (AK). These prema-
lignant lesions exhibit up to 20% probability of becoming
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genetic changes as found in SCCs, such as mutations in the p53
gene (Ziegler et al, 1994). The AK can be graded into ‘basic’ and
more progressive, hypertrophic or proliferating subtypes (Weedon,
1997), the latter being also classified as carcinoma in situ (Callen,
1991). Little is known about the cellular and molecular changes
associated with the transition of premalignant to malignant (inva-
sive) skin lesions in humans. Experimental in vitro models have
been developed and different stages in the carcinogenesis process
characterized at the genetic and phenotypic level (Boukamp et al,
1995; Fusenig and Boukamp, 1998). Distinct patterns of angio-
genesis in heterotransplants in nude mice (Skobe et al, 1997)
indicated that persistent angiogenesis and increased vasculariza-
tion are restricted to malignant tumours in this model. However,
comparable in situ studies on SCCs of human skin are lacking
correlate to the onset of tumour angiogenesis with distinct stages
in skin cancer development (Urbach and Graham, 1962).
In order to analyse the angiogenic switch in epithelial skin
tumour development, we examined vascular density in the
stroma of normal skin, AK, its hypertrophic form, and early- as
well as late-stage SCCs. As the angiogenic switch is considered a
result of an imbalance between angiogenesis inductors and
inhibitors (Hanahan and Folkman, 1996), we further investigated
the expression of the most potent angiogenic factor vascular
endothelial growth factor (VEGF) (Folkman, 1995; Weninger et
al, 1996) at the RNA and protein level. We here demonstrate that
in epithelial skin carcinogenesis tumour vascularization is signif-
icantly increased only in later stage SCCs and that this is not
correlated with a different expression level of VEGF in these
lesions.
MATERIALS AND METHODS
Patients and materials
Formalin-fixed, paraffin-embedded specimens from 51 patients
with different epithelial lesions were analysed including AK (14),
its hypertrophic form (12) and SCCs (25) obtained for therapeutic
purposes with fully informed consent of patients (Table 1). The
SCCs were subdivided into two groups following the classification
of Breuninger (1990) on the basis of tumour thickness and depth of
infiltration. According to this microstaging of SCCs of the skin,
nine SCCs had a tumour thickness of less than 2 mm and were still
confined to the corium and thus classified as early stages. Sixteen
cases had a thickness of more than 2 mm and their invasive front
extended into the subcutaneous fat, and were thus classified as late-
stage SCCs exhibiting a higher probability to metastasize
(Breuninger, 1990). Two SCCs of the lip were also included in this
group of late-stage SCCs although their thickness was less than
2 mm, but they had infiltrated the subcutaneous fat. In addition,
five recurrent tumour specimens were included: two of each
belonging to the groups of early and late SCCs and one was diag-
nosed as hypertrophic AK. Significant neurotropism (perineural
spread) often associated with high recurrence and metastasis rate
(Goepfert et al, 1984) was not observed in any of the tumours.
These tumour specimens were compared with ten normal skin
biopsies of comparable anatomical locations obtained for thera-
peutic purposes (skin transplantation, tumour periphery) exhibiting
no histopathological alterations. Haematoxylin and eosin (H&E)-
stained sections of the paraffin-embedded blocks were reviewed
and the tumour stages classified by a dermatopathologist not
involved in the analysis of angiogenesis. In none of the patients had
metastases been observed for a period of more than 5 years.
CD31 immunohistochemistry
Sections (5-mm thick) were cut from the retrieved tumour blocks,
dewaxed and rehydrated in graded ethanol. Endogenous peroxi-
dase was blocked with 0.3% hydrogen peroxide for 15 min. To
unmask hidden epitopes, sections were digested with protease
type XXIV (Sigma, Deisenhofen, Germany; 10 mg ml–1) at 37°C
for 15 min. Vessels were visualized by immunostaining with a
monoclonal antibody against CD31 (clone JC70/A; Dako,
Glostrup, Denmark). Sections were incubated for 6 h (the optimal
time) with the primary antibody diluted 1:40 in phosphate-
buffered saline (PBS) and subsequently developed using a strep-
tavidin–biotin–peroxidase system (Amersham, Braunschweig,
Germany). Visualization of the antibody complex was achieved
with a nickel-enhanced diaminobencidin reaction (Hsu et al,
1982) resulting in black staining of endothelial cell membranes.
Sections were counterstained by a modified Masson–Goldner
protocol omitting haematoxylin.
Quantitation of vessel density
Sections were screened at a magnification of 100´ for areas of
highest microvessel density, so-called ‘hot spots’ (Weidner et al,
1991; Van Hoef et al, 1993) and three such areas were analysed per
section. While focusing on the margins of epithelial tissues, areas
next to hair follicles and glands were avoided. At a magnification
of 200´ the black-stained vessels were counted in a square grid
defining an area of 0.09 mm2 (349 mm  ´ 264 mm). All black-
stained single cells or clusters of cells which were separated from
other stained areas and vessels of all sizes were counted.
Lymphatic vessels were not marked by the antibody. Vascular
density was defined as the mean vessel count of three areas
analysed per section. Results obtained from different sections of
the same tumour showed good reproducibility (data not shown).
Additionally, vessel density was determined by computer-assisted
image analysis in the same grid-defined area used for the manual
count at a magnification of 200´ using a Leica Quantimet
600QWin-Image Analysis System equipped with a 3CCD camera.
The black-stained vessels were detected automatically using the
Hue-Saturation-Intensity (HSI) system. In cases where interfer-
ence was observed with other dark material such as erythrocytes or
horn material, this was corrected interactively. Vascular density
was calculated as the mean of three measurements and blotted as
area per cent.
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Table 1 Classification of stages of skin carcinomas
n Depth of Tumour Broders’
infiltration thickness grading
Normal skin 10 –
Actinic keratosis 14 –
Hypertrophic a. k. 12 –
(carcinoma in situ)
Early SCC 9 Corium <2 mm I
Late SCC 16 Subcutaneous fat >2 mm I–IVVascularity in human skin epithelial tumours 593
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Figure 1 Immunohistochemical staining of capillaries by a CD 31 antibody in: the dermis of normal skin (A), actinic keratosis (AK) (B) (most of the keratotic
material was lost during processing), in the hypertrophic form of AK (C), in early-stage squamous cell carcinoma (SCC) (D), and a well differentiated (E) as well
as undifferentiated (F) late-stage SCC. Small and large blood vessels are clearly discernible by staining of endothelial cell membranes (G). Vascular density
was assayed in ‘hot spot’ areas at the epithelial–stromal border in a frame of 349 mm ´ 264 mm as shown in an SCC section (H) at lower magnification.
Magnification in A–F 144´, in G 288´, in H 72´ (bars: 23 mm). Counterstaining in A, B, C, E, G with a modified Masson–Goldner protocol; in D, F, H with
haematoxylinStatistical analysis
The mean area percentage and the mean manual count data have
been analysed with the MS Excel software and the statistics
program ADAM. The Wilcoxon rank sum test with multiple
comparison was used to test differences in vascular density values
(vessel count/vessel area) of the five tumour stages at a signifi-
cance level of 0.01. The high level of significance was chosen to
compensate for the multiple comparison of five groups (adjusting
the a-parameter).
Assessment of chronic inflammatory cell infiltrate
Parallel H&E-stained sections were assessed for inflammatory
infiltration consisting mainly of lymphocytes. Cell density was
screened by a pathologist not involved in determining vessel
density and classified as no infiltration (–), low degree (+), inter-
mediate degree (++) and strong degree of infiltration (+++).
Determination of proliferative activity
Parallel sections of normal skin and four early as well as seven late
SCCs were analysed for proliferating cells by immunostaining
with the monoclonal antibody Mib-1 (Ki-67; Dianova, Hamburg,
Germany) after 30 min microwave incubation and using the same
immunohistochemical method (DAB-nickel) as for the identifica-
tion of endothelial cells. At least 100 proliferating cells per
specimen were counted in basal layers and zones of proliferation
respectively.
In situ hybridization of VEGF-RNA
Human cDNA (649 bp) encoding human VEGF165 in Bluescript
KS– vector (Stratagene) (Keck et al, 1989), generously provided
by Drs H Weich and D Marmé (Freiburg, Germany) was used as a
probe. The in situ hybridization was essentially performed as
described (Moorman et al, 1992). In brief, 35S-labelled RNA
probes for VEGF were prepared using T3 or T7 RNA-polymerase
(for antisense and sense respectively) according to the manu-
facturer’s instructions (Boehringer Mannheim). Three paraffin
sections per tumour stage, parallel to those used for determining
vascular density, were pretreated, hybridized and washed at high
stringency as described (Moorman et al, 1992). For autoradiog-
raphy, slides were coated with NTB-2 film emulsion and exposed
for 4 weeks. After the film was developed, the sections were
counterstained with haematoxylin.
VEGF immunohistochemistry
Indirect immunohistochemistry using a polyclonal antibody against
VEGF165 (1:20; Calbiochem, Cambridge, Cat. No. GF 25) was
performed on parallel sections to those specimens used for in situ
hybridization. Pretreatment of sections was performed by a 30 min
incubation in 0.05% Saponin (Sigma, Deisenhofen, Germany).
Background staining was blocked by incubating the slides 15 min
in streptavidin (1 mg ml–1; Sigma, Deisenhofen, Germany) and
normal goat serum (1:10, Dianova, Hamburg, Germany) before
application of the primary antibody. The secondary antibody was
diluted in PBS with 5% human serum (Dianova, Hamburg,
Germany). Recombinant VEGF165 (Escherichia coli), kindly
provided by Dr D Marmé (Freiburg, Germany), was used for
neutralizing the antibody as a negative control (ligand/antibody =
9.7/1, based on protein mass). Evaluation of RNA and protein
expression of VEGF was based both on the area and intensity of
staining.
RESULTS
Selected tumour stages of skin SCCs
Different stages of premalignant lesions and SCCs were classi-
fied on the basis of H&E-stained sections by a dermatopatholo-
gist (Table 1) and characteristic tumour stages selected for
analysis of vessel density. In addition to normal unaffected skin
(Figure 1A), actinic keratoses were analysed. They were subdi-
vided into two classes based on their degree of hyperplasia and
dysplasia. The first representing the typical appearance of a
hyperparakeratotic epithelium of more or less atypical
keratinocytes lacking the normal stratified arrangement of the
epidermis (Figure 1B). Following the definitions of Weedon
(1997) the hypertrophic form of AK (also called proliferating
AK) was characterized by a hyperplastic epithelium exhibiting a
higher degree of dysplasia and deeper indentations of atypical
basal keratinocytes into the dermis (Figure 1C). Invasive SCCs
were subdivided in low-risk and higher risk SCCs depending on
their tumour thickness and depths of infiltration (Breuninger 
et al, 1990) and classified as early stages (< 2 mm thickness)
(Figure 1D) and late-stage SCCs (> 2 mm) (Figure 1 E,F). The
latter lesions usually have a moderate tendency for metastasis,
whereas metastatic probability increases strongly when skin
SCCs reach a thickness of more than 6 mm (Breuninger et al,
1990). Most SCCs had a moderate to low degree of differentia-
tion with only a few being of an undifferentiated phenotype
(Figure 1F). However, no distinction was made between these
subtypes according to Broders’ (1932) classification.
Immunohistochemical detection of blood vessels
When comparing different staining procedures for identifying
blood vessels using antibodies against factor VIII-related Ag,
collagen type IV and CD31/PECAM respectively, the latter gave
the best and most consistent results. With CD31 antibodies
staining was most uniform, intense, and with no or very low back-
ground (see Figure 1). Using the nickel enhancement procedure
endothelial cells forming the walls of smaller and larger vessels
could be easily identified and even very small vessels clearly
recognized (Figure 1G). Vessels were counted and the density of
the stained area morphometrically assessed in three framed areas
per section choosing ‘hot spots’ of vascular density as indicated in
Figure 1H.
Late angiogenic switch in skin carcinogenesis
In sections of anatomically related normal skin, a typical capillary
bed of a normal, uninflamed and non-irritated dermis was visible
(Figure 1A). Increased vascular density was usually noticed
around hair follicles and sebaceous glands, but these areas were
excluded. In AK, both in the ‘classical’ and the hypertrophic form,
the thickened epidermis was in some cases lined with increased
vessel density but this was confined to a small subepidermal zone
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Figure 2 Correlation of manual counts and computer-assisted quantitation of stained area of all specimens yielding a correlation coefficient of 0.80
Figure 3 Vascular density in different skin lesions analysed by computerized measurements of stained areas (n) and manual count (–u–). The localization of
the different lesions in h: head, f: face, l: lip, e: ear, t: trunk, a: arm, x: leg, ?: not reported(Figure 1 B,C). In early-stage SCCs the invading tumour tips were
surrounded by a net of small- and medium-sized vessels which
sometimes covered a larger area, while generally resembling those
seen in AK (Figure 1D). Vascularization was clearly increased in
late-stage SCCs and particularly obvious in so-called ‘hot spots’,
irrespective of whether tumours were keratinized or undifferenti-
ated (Figure 1 E,F).
Both methods of quantitation: manual count and computer-
assisted analysis of stained area showed a good correlation coeffi-
cient of 0.80 (Figure 2) instead of some variations in vessel
staining due to different vessel size and section planes (see Figure
1). The close correlation was similarly obvious when the manual
counts were blotted together with the area measurements for the
different tumour stages (Figure 3). With few exceptions, the values
of both evaluation methods were very similar, although some
individual variations were visible in the three tumour groups.
Nevertheless, for every group high correlations were calculated
(normal skin: 0.68; AK: 0.64; hypertrophic AK: 0.98; early SCC:
0.89; late SCC: 0.81).
Quite remarkably, the assessed vessel density did not differ
much between normal skin and early SCCs irrespective of local-
ization (Figures 3 and 4). Three of the four specimens with higher
vascularizations in hypertrophic AK and early SCC (arrows) were
identified as locally recurrent tumours known to behave more
aggressively than the primary lesion. In late-stage SCCs, however,
vascular density was clearly increased above the level of the
premalignant stages. When calculated by the Wilcoxon rank sum
test with multiple comparison, a significant difference in vascular
density was evident only in late-stage SCCs (late SCC vs normal
skin and AK: P < 0.00005; vs hypertrophic AK: P = 0.0004, and
vs early SCC: P = 0.0002). No other group of lesions exhibited
significant differences in vessel density when compared with
normal skin or between the different groups (AK vs normal skin:
P = 0.4366; hypertrophic AK vs normal skin: P = 1.000; vs AK: 
P = 0.3217; early SCC vs normal skin: P = 0.3562; vs AK: 
P = 0.1245; vs hypertrophic AK: P = 0.6511).
Impact of chronic inflammatory cell infiltrates and
tumour cell proliferation
In order to exclude that changes not associated with tumour stage
would have contributed to the observed vascular density in the
tumour stroma, the frequency of white blood cells, mainly
lymphocytes, was assessed by an arbitrary scale on H&E-stained
sections at a magnification of 200´. While there was essentially no
inflammatory cell infiltrate in normal skin, this level was clearly
higher, though of varying intensity, in actinic keratosis and in
early- as well as late-stage SCCs. However, there was no correla-
tion between the levels of inflammatory cell infiltration and
vascular density as determined on parallel sections both when
overall and focal intensities were compared. This documented that
vessel density was not significantly affected by inflammatory cell
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Figure 4 Statistical evaluation of vascular density as measured by
computerized stained area analysis in the different skin lesions. Both single
values (¡) as well as calculated means (u) with standard deviation are given.
Three of the four strongly vascularized lesions of hypertrophic AKs and early
SCCs as well as two late SCCs were identified as recurrent lesions (arrows)
Figure 5 Proliferating cells identified as labelled nuclei stained by the Mib-1
(Ki67) antibody in normal epidermis (A), early (B) and late (C) SCCs
(haematoxylin, magnification A–C 288´; bar: 23 mm)infiltrates. In addition, no basic disease of the tumour-bearers (e.g.
diabetes or psoriasis) was evident which could have effected
vascular density.
When the rate of proliferating (Mib-1-positive) cells was
assessed in selected specimens of early and late SCCs (Figure 5),
there was a visible increase in proliferating cells in late SCCs
(early SCC: 38% ± 5%; late SCC 52% ± 11%), which, however,
was statistically not significant. Kerschmann et al (1994) also
reported a positive trend but no significant change in mean prolif-
eration fractions according to increasing tumour grades. This indi-
cated that the significant higher rate of vascularization in these
more advanced tumour stages was not associated with a higher
proliferative activity of tumour cells. In particular, individual
tumours of late SCCs with highest vascular density did not exhibit
the highest proliferative activity so that both parameters were not
correlated.
Expression of VEGF RNA and protein
In order to determine whether the increased vascular density of
late stage SCCs was caused by an elevated synthesis of an angio-
genic inducer, the RNA and protein levels of the most potent
angiogenic factor, the VEGF were analysed in parallel sections. By
radioactive in situ hybridization strong VEGF expression in
epithelial cells could be detected, however, no differences were
obvious between premalignant and malignant lesions (Figure 6).
Expression was similarly intense in AK (Figure 6A), its hyper-
trophic form (not shown) as well as early- (Figure 6B) and late-
stage SCCs (Figure 6C), while the sense probe only yielded some
background labelling (Figure 6D). The epidermis of normal skin
also expressed VEGF-RNA, although at a lower level than the
tumour lesions.
Label was observed in all epidermal strata, though with a
tendency to more intensity in differentiated layers, and in SCCs it
was rather homogeneously distributed with no distinct inter-
tumoural variability.
Comparably, VEGF protein was detected by indirect immuno-
histochemistry in similar intensity in AK (not shown), its hyper-
trophic form (Figure 6E) and in early (Figure 6F) and late SCCs
(Figure 6G). In normal skin the staining of the protein was very
weak.
Again the staining was more intense over differentiated cells
and there was a homogenous staining pattern in each group. As
control for the antibody specificity, the immunoreaction was abol-
ished, as shown for late-stage SCCs by blocking the antibody with
recombinant human VEGF (Figure 6H).
DISCUSSION
A considerable body of research has documented that tumour
growth and metastasis require persistent new blood vessel growth
(Folkman, 1995). Based on the frequently observed correlation
between angiogenesis and rapid tumour expansion the question
has been raised as to when angiogenesis is activated in the course
of tumour development and whether the onset of tumour angio-
genesis can be a diagnostic parameter (Srivastava et al, 1988;
Carrau et al, 1995; Weidner, 1995; Staibano et al, 1996). There is
increasing evidence that angiogenesis is induced during the early,
preneoplastic stages of tumour development (Hanahan and
Folkman, 1996). The clues initially came from experimental
carcinogenesis models using transgenic mice which express
distinct stages of tumour development (Coussens et al, 1996;
Smith-McCune et al, 1997). In three different mouse models of
carcinogenesis including islet cell carcinoma, dermal fibrosarcoma
and epidermal SCC, the angiogenic switch occurred during early
stages preceding the appearance of the solid tumours (Hanahan
and Folkman, 1996). This suggested that the regulation of angio-
genesis is an important, potentially rate-limiting step in the
pathway to many solid tumours.
In human cancer, vessel density in invasive tumours has been
demonstrated to be a significant prognostic indicator for both
breast (Weidner et al, 1991) and cervical cancers (Schlenger et al,
1995). In both mammary duct and uterine cervix the angiogenic
switch occurred before the tumour started to invade (Guidi et al,
1994; Smith-McCune and Weidner, 1994). The level of angio-
genesis in the premalignant lesions did not correlate with the
degree of inflammation but with the grade of intraepithelial
neoplasia. From these as well as the experimental data it was
suggested that the ability to induce angiogenesis precedes the
conversion of premalignant to malignant tumours (Hanahan and
Folkman, 1996).
In contrast to these observations, our findings demonstrate that
in skin epithelial neoplasia a significant increase in vascularization
occurs only in later stage SCCs. Even more astonishingly, the
mean vessel density in the premalignant lesions of actinic keratosis
and early stages of invasive SCCs does not differ significantly
from that in the dermis of normal skin. The few exceptions with
high vascular density among the early skin lesions are found in
recurrent tumours and may either be due to previous treatment or
increased malignancy of the recurrent tumour. These findings indi-
cate that in epithelial skin malignancies the angiogenic switch
occurs late during tumour progression and not in premalignant and
pre-invasive stages.
This delayed onset of increasing tumour vascularization was not
correlated to the level of expression of the most potent angiogenic
factor VEGF. The expression levels of VEGF (both at the RNA
and protein level) were similar in all lesions from the premalignant
actinic keratoses to the late-stage carcinomas. This is in agreement
with earlier reports, demonstrating VEGF expression in malignant
skin carcinoma as well as benign tumours, such as kerato-
akathoma and even in normal epidermis (Detmar et al, 1994;
Weninger et al, 1996). Moreover, VEGF expression was observed
in epidermal hyperplastic diseases, such as psoriasis and is suppos-
edly induced by hypoxic conditions in the expanded epithelia
(Detmar et al, 1997). The functional significance of VEGF in
angiogenesis associated with healing skin wounds (Brown et al,
1992) as well as its function on dermal vascular endothelial cells
(Detmar et al, 1995) has been documented. In contrast to Weninger
et al (1996) who described a membrane staining of keratinocytes
we found a cytoplasmatic staining pattern for the VEGF protein
especially in suprabasal cell layers, a pattern comparable to that
described by Detmar et al (1994, and references therein) using the
same antibody. The lack of correlation between VEGF expression
and tumour stages might indicate that this angiogenic factor may
not be the rate-limiting step for the increased tumour vasculariza-
tion. This may be determined by other factors as well and depend
on the expression of their respective receptors on vascular
endothelial cells. Recent studies on an experimental skin carcino-
genesis model had demonstrated a decisive role of VEGF receptor
2 expression for malignancy-associated angiogenesis (Skobe et al,
Vascularity in human skin epithelial tumours 597
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Figure 6 Expression of VEGF as revealed by radioactive in situ hybridization in actinic keratosis (A), early SCC (B) and late SCC (C); D: corresponding sense
probe control. Protein localization by immunohistochemistry revealed a similar distribution with preference to differentiating cells in hypertrophic AK, E; early
SCC, F; late SCC, G; as a control, in a late SCC (H) staining was abolished after absorption of the antibody with recombinant VEGF (haematoxylin-
counterstaining, magnification A–D, G–H: 144´, E: 288´, F: 72´; bars: 23 mm)1997). While VEGFR-2 was only transiently activated in trans-
plants of benign keratinocytes, it was continuously up-regulated in
the endothelial cells of malignant stroma concomitant with
ongoing angiogenesis and invasion. Moreover, the functional
significance of this correlation was proven by blocking
VEGF/VEGFR-2 interaction resulting in drastic reduction of
vascularization accompanied by abrogation of tumour cell inva-
sion (Skobe et al, 1997). The mechanism of VEGFR-2 activation
and whether this process plays a decisive role in the late onset of
skin SCC angiogenesis remains to be determined.
So far, there have been no reports studying the onset of angio-
genesis in epithelial skin tumour development in man. A higher
vascular density has been observed in more aggressive than in
relatively benign basal cell carcinomas (Staibano et al, 1996).
Squamous cell carcinomas showed a higher microvessel density
than basal cell carcinomas (Weninger et al, 1996), but similar
vascularization than the benign keratoakanthomas (Weninger et al,
1997). However, in these studies no comparison with tumour
stages of SCCs and vascular density has been made.
This is in contrast to malignant melanoma, where increased
angiogenesis was observed with the transition from the radial-
growth-phase tumours (usually having a good prognosis) to the
vertical-growth-phase (Marcoval et al, 1997). Thus, a high
vascular count in thin primary melanomas is considered predictive
of fatal metastatic disease (Barnhill et al, 1992; Barnhill and Levy,
1993; Graham et al, 1994). Similarly, in SCCs of the head and
neck, correlations between microvessel density, bad prognosis and
metastatic probability (Gasparini et al, 1993; Zätterström et al,
1995) have been reported, while others found no correlation
between angiogenesis and tumour stage or prognosis (Carrau et al,
1995; Tahan and Stein, 1995). Whether these discrepancies are due
to the analysis of different tumour stages, localizations, or methods
of analysis, is not clear.
There has been a long debate on the best way to assess tumour
vascularization (Vermeulen et al, 1996). Mostly factor-VIII-related
antibodies are used to stain endothelia, but this antibody may not
highlight all intratumour microvessels, whereas CD31 antibodies
are apparently more sensitive, in particular on paraffin-embedded
sections (DeYoung et al, 1993; Weidner, 1995; Vermeulen et al,
1996). In order to obtain more objective data, we have, in addition
to the classical blood vessel count, analysed the vessel density
morphometrically using the same areas as selected for manual
vessel counting. The data show a remarkable accordance of the
values with only very few exceptions where vessel counting gave
higher values than morphometric analysis. Comparing the results
of both methods and in agreement with published data, we feel
quite confident about the reliability of this information (Van Hoef
et al, 1993; Barbareschi et al, 1995).
In contrast to skin SCCs, head and neck tumours tend to metas-
tasize quite early and this may be associated with a different state
of vascularization. In skin SCCs, the rate of metastasis is low,
reaching only 4.5% in tumours exhibiting a thickness between 2
and 6 mm and approaching 15% in SCCs exceeding a thickness of
6 mm (Breuninger et al, 1990). In comparison, the usual TNM
classification uses much larger dimensions (T1 < 2 cm; T2 > 2 cm)
and is thus not appropriate for the microstaging of early skin carci-
nomas. In the absence of generally accepted criteria for evaluating
early SCC stages we followed Breuniger’s classification, which is
considered more relevant than Broders’ grading based on the
degree of differentiation. Based on these criteria, we found an
interesting correlation: the non-metastasizing carcinomas (<2 mm)
did not show increased microvessel density. Only in those tumours
exceeding 2 mm in thickness the vascular density was signifi-
cantly increased. Notably, microvessel density was not influenced
by the location of the tumour but just depended on its thickness
and depth of penetration into the subepithelial stroma. This
suggests that in skin SCCs increased vascular density might be a
prognostic criterion and associated with tumour stages exhibiting
increased metastatic probability.
The discrepancy between the experimental skin carcinogenesis
data on transgenic mouse models (Hanahan and Folkman, 1996)
and our data, may be partly explained by species differences and
the discrepancy between virally- and UV-induced tumours.
Importantly, experimentally induced mouse skin and genuine
human tumours differ considerably in the latency periods of their
development, i.e. by the different dynamics of tumour progression.
On the other hand, skin epithelial tumours, as long as they remain
surface tumours, may not require increased angiogenesis, as they
are quite well nourished by diffusion similar to the situation of the
parent tissue, the epidermis. Thus, increased angiogenesis would
only be required with larger tumour masses, and consequently
increased hypoxia within those areas (Detmar et al, 1997). On the
other hand, angiogenesis and tumour vascularization may not only
be required for nutrition and gas exchange but may actively partic-
ipate in the invasion process by producing proteases or serving as
trails for migrating tumour cells (Hamada et al, 1992; Rak et al,
1996; Skobe et al, 1997). Consequently, increased tumour vascu-
larization would then not only be associated with enhanced inva-
sion but may play an active part in tumour progression to the
metastatic phenotype (Weidner, 1995; Ellis and Fidler, 1996).
Thus, one may speculate that the late onset of increased tumour
vascularization in skin SCCs may be associated with the low
metastasizing capacity of these tumours.
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